54 related articles for article (PubMed ID: 10087482)
1. [Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis].
Miyazaki H; Matsuoka H; Cooke JP; Usui M; Ueda S; Okuda S; Imaizumi T
J Cardiol; 1999 Feb; 33(2):105-6. PubMed ID: 10087482
[No Abstract] [Full Text] [Related]
2. Is asymmetric dimethylarginine a novel marker of atherosclerosis?
Böger RH; Bode-Böger SM; Matsuoka H; Miyazaki H; Usui M; Ueda S; Okuda S; Imaizumi T; Cooke JP
Circulation; 2000 Apr; 101(14):E160-1. PubMed ID: 10758065
[No Abstract] [Full Text] [Related]
3. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis.
Miyazaki H; Matsuoka H; Cooke JP; Usui M; Ueda S; Okuda S; Imaizumi T
Circulation; 1999 Mar; 99(9):1141-6. PubMed ID: 10069780
[TBL] [Abstract][Full Text] [Related]
4. Endogenous production of nitric oxide synthase inhibitors.
Anthony S; Leiper J; Vallance P
Vasc Med; 2005 Jul; 10 Suppl 1():S3-9. PubMed ID: 16444863
[TBL] [Abstract][Full Text] [Related]
5. Elevation of an endogenous inhibitor of nitric oxide synthase in diabetic rat serum.
Xiong Y; Lu R; Li YJ; Deng HW
Zhongguo Yao Li Xue Bao; 1997 Nov; 18(6):511-4. PubMed ID: 10322907
[TBL] [Abstract][Full Text] [Related]
6. Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease.
Bode-Böger SM; Scalera F; Kielstein JT; Martens-Lobenhoffer J; Breithardt G; Fobker M; Reinecke H
J Am Soc Nephrol; 2006 Apr; 17(4):1128-34. PubMed ID: 16481412
[TBL] [Abstract][Full Text] [Related]
7. Determination of dimethylated arginines in human plasma by high-performance liquid chromatography.
Tsikas D; Junker W; Frölich JC
J Chromatogr B Biomed Sci Appl; 1998 Jan; 705(1):174-6. PubMed ID: 9498688
[No Abstract] [Full Text] [Related]
8. Asymmetric dimethylarginine and hypertension in cerebral small vessel disease.
Tsuda K
Stroke; 2007 Jul; 38(7):e48; author reply e49. PubMed ID: 17510451
[No Abstract] [Full Text] [Related]
9. Treatment with niacin lowers ADMA.
Westphal S; Borucki K; Luley C; Martens-Lobenhoffer J; Bode-Böger SM
Atherosclerosis; 2006 Feb; 184(2):448-50. PubMed ID: 16376893
[No Abstract] [Full Text] [Related]
10. Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus.
Abbasi F; Asagmi T; Cooke JP; Lamendola C; McLaughlin T; Reaven GM; Stuehlinger M; Tsao PS
Am J Cardiol; 2001 Nov; 88(10):1201-3. PubMed ID: 11703973
[No Abstract] [Full Text] [Related]
11. Determination of NG,NG-dimethyl-L-arginine, an endogenous NO synthase inhibitor, by gas chromatography-mass spectrometry.
Albsmeier J; Schwedhelm E; Schulze F; Kastner M; Böger RH
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 809(1):59-65. PubMed ID: 15282094
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of l-arginine transport in platelets by asymmetric dimethylarginine and N-monomethyl-l-arginine: effects of arterial hypertension.
Brunini T; Moss M; Siqueira M; Meirelles L; Rozentul A; Mann G; Ellory J; Soares de Moura R; Mendes-Ribeiro A
Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):738-40. PubMed ID: 15554917
[TBL] [Abstract][Full Text] [Related]
13. Asymmetric dimethylarginine, an endogenous NO synthase inhibitor, in human breast milk.
Tsukahara H; Nagasaka H
Early Hum Dev; 2010 Feb; 86(2):69-70. PubMed ID: 20117887
[No Abstract] [Full Text] [Related]
14. [Asymmetric dimethylarginine: predictor of cardiovascular diseases?].
Németh B; Kustán P; Németh Á; Lenkey Z; Cziráki A; Kiss I; Sulyok E; Ajtay Z
Orv Hetil; 2016 Mar; 157(13):483-7. PubMed ID: 26996894
[TBL] [Abstract][Full Text] [Related]
15. L-arginine analogs as alternate substrates for nitric oxide synthase.
Luzzi SD; Marletta MA
Bioorg Med Chem Lett; 2005 Sep; 15(17):3934-41. PubMed ID: 15993059
[TBL] [Abstract][Full Text] [Related]
16. Roles of endogenous nitric oxide synthase inhibitors and endothelin-1 for regulating myometrial contractions during gestation in the rat.
Momohara Y; Sakamoto S; Obayashi S; Aso T; Goto M; Azuma H
Mol Hum Reprod; 2004 Jul; 10(7):505-12. PubMed ID: 15155819
[TBL] [Abstract][Full Text] [Related]
17. Role of neuronal nitric-oxide synthase in estrogen-induced relaxation in rat resistance arteries.
Lekontseva O; Chakrabarti S; Jiang Y; Cheung CC; Davidge ST
J Pharmacol Exp Ther; 2011 Nov; 339(2):367-75. PubMed ID: 21807885
[TBL] [Abstract][Full Text] [Related]
18. Potent and selective inhibition of neuronal nitric oxide synthase by N omega-propyl-L-arginine.
Zhang HQ; Fast W; Marletta MA; Martasek P; Silverman RB
J Med Chem; 1997 Nov; 40(24):3869-70. PubMed ID: 9397167
[No Abstract] [Full Text] [Related]
19. Asymmetrical dimethylarginine and multiple organ failure.
Cynober L
Clin Nutr; 2003 Oct; 22(5):505; author reply 505-6. PubMed ID: 14512040
[No Abstract] [Full Text] [Related]
20. Should we measure asymmetric dimethylarginine in patients with coronary artery disease?
Kielstein JT; Cooke JP
Clin Chem; 2007 Feb; 53(2):161-3. PubMed ID: 17259245
[No Abstract] [Full Text] [Related]
[Next] [New Search]
